EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Apigenin: A Therapeutic Agent for Treatment of Skin Inflammatory Diseases and Cancer

Ji Hye Yoon iD, Mi-Yeon Kim, Jae Youl Cho iD

International Journal of Molecular Sciences · 12.01.2023 · 24 (2) · 1498

DOI: 10.3390/ijms24021498 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.01.2023. Verfasst von Ji Hye Yoon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biocosmetics, Sungkyunkwan University, Suwon 16419, Republic of Korea. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Skin Neoplasms, Vitiligo. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The skin is the main barrier between the body and the environment, protecting it from external oxidative stress induced by ultraviolet rays. It also prevents the entrance of infectious agents such as viruses, external antigens, allergens, and bacteria into our bodies. An overreaction to these agents causes severe skin diseases, including atopic dermatitis, pruritus, psoriasis, skin cancer, and vitiligo. Members of the flavonoid family include apigenin, quercetin, luteolin, and kaempferol. Of these, apigenin has been used as a dietary supplement due to its various biological activities and has been shown to reduce skin inflammation by downregulating various inflammatory markers and molecular targets. In this review, we deal with current knowledge about inflammatory reactions in the skin and the molecular mechanisms by which apigenin reduces skin inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicSkin NeoplasmsVitiligoHumansApigeninSkinInflammation

Stichwörter der Autor:innen

apigeninatopic dermatitisflavonoidprurituspsoriasisskinskin cancerskin inflammationvitiligo

Substanzen

Apigenin

Autor:innen und Institutionen

  • Department of Biocosmetics, Sungkyunkwan University, Suwon 16419, Republic of Korea.
  • School of Systems Biomedical Science, Soongsil University, Seoul 06978, Republic of Korea.
  • Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Republic of Korea.

ORCID-Profile: Ji Hye Yoon, Jae Youl Cho

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Yoon, J. H., Kim, M. Y., & Cho, J. Y. (2023). Apigenin: A Therapeutic Agent for Treatment of Skin Inflammatory Diseases and Cancer. International Journal of Molecular Sciences, 24(2), 1498. https://doi.org/10.3390/ijms24021498

Vancouver

Yoon JH, Kim MY, Cho JY. Apigenin: A Therapeutic Agent for Treatment of Skin Inflammatory Diseases and Cancer. International Journal of Molecular Sciences. 2023;24(2):1498. doi:10.3390/ijms24021498

BibTeX
@article{Yoon2023,
  author = {Yoon, Ji Hye and Kim, Mi-Yeon and Cho, Jae Youl},
  title = {Apigenin: A Therapeutic Agent for Treatment of Skin Inflammatory Diseases and Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {2},
  pages = {1498},
  doi = {10.3390/ijms24021498}
}
Kostenlos starten →